The Department wishes to announce that Professor Dame Sarah Gilbert has been appointed to the role of Deputy Head of Department of the Nuffield Department of Medicine for a five-year term.
An important step toward advancing vaccines for human use, a recent study has shown that inhaled vaccines could potentially improve efficiency and reduce viral transmission.
A new blood test \u2013 powered by machine learning \u2013 has shown real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect. Developed by a team of researchers and co-lead by the Centre for Human Genetics\u2019 Dr Dimitris Vavoulis, the test accurately detected six cancer types and could distinguish between people with and without cancer.
The Royal Society of Biology have recognised Associate Professor Benjamin Schuster-B\u00f6ckler from NDM's Ludwig Institute for Cancer Research as a Fellow in their January 2025 nominations round.
Mahidol Oxford Tropical Medicine Research Unit (MORU) have led the world\u2019s largest study on the use of hydroxychloroquine and chloroquine to prevent COVID-19. With results showing moderate protection against the virus, the trial involved over 4,600 participants and found a 15% reduction in symptomatic COVID-19 among those who took the medications compared to those who took a placebo.
A study aimed at increasing understanding of how cells function has received funding of \u00a36.4 million. Led by the University of Strathclyde, NDM\u2019s Division of Structural Biology (STRUBI) and collaborators from other universities across the UK will be working together to increase understanding in this area of research.
NDM\u2019s Dr Lennard Lee has been featured in Fujifilm Europe\u2019s 90th Anniversary celebration documentary series, which honours 20 exceptional innovators helping to shape the future across Europe. Dr Lee has been recognised as a UK exemplar for his groundbreaking contributions to the cancer vaccines research field, accelerating the uptake of digital trials, and demonstrating a faster, simpler, and more efficient model for clinical trials.
A new study led by Professor Ignacio Melero of NDM's Centre for Immuno-oncology and the University of Navarra and has highlighted a way to combat resistance to cancer immunotherapy in solid tumours by using antibodies that target GDF-15 protein.
A team of scientists in the UK, Kenya and Tanzania will soon find out the extent to which chikungunya, a debilitating mosquito-borne disease causing large outbreaks in Asia and South America, is also affecting countries in East Africa.
Professor Anneke Lucassen will chair the Public and Community Engagement with Research Advisory Board and launch the 2024-2029 strategy as the new Academic Champion for Oxford University.
The Medical Research Council (MRC), part of UKRI, is launching its first two Centres of Research Excellence (CoRE), which will develop transformative new advanced therapeutics for currently untreatable diseases. Oxford is leading one of these Centres and co-leading the other. Together, these international collaborations will receive up to \u00a350 million each over 14 years.
PSI researcher Md Zakiul Hassan, the inaugural Oxford-MoH Foundation DPhil Scholar, has been recognised as 2024 ISID Emerging Leader in International Infectious Diseases. The award from the International Society for Infectious Diseases acknowledges early-career excellence in the field.
Dr Xin Hui Chan has won the competitive 2024 Barnett Christie Lecture award of the British Infection Association. As part of the award, Dr Chan delivered a lecture entitled \u2018Drugs for Tropical Infections: Challenges, Opportunities, and the Infectious Disease Physician\u2019.
Researchers at NDM\u2019s Ludwig Cancer Research, the \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne and other Oxford departments report the use of surfactant-supported assembly of freestanding microscale hydrogel droplets to construct iontronic modules and biointerfaces.
An injection given during some asthma and chronic obstructive pulmonary disease (COPD) attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30 percent.
The Kenya Medical Research Institute (KEMRI) has signed a seven-year memorandum of agreement with the Wellcome Trust and the University of Oxford. Under this collaboration, Wellcome has awarded \u00a391 million (KES 15 billion) to support research over the next seven years. KEMRI have been collaborating with the Wellcome Trust and the University of Oxford on improving health through research for over 35 years.
A new study by NDM researchers and collaborators has found methaemoglobin levels during treatment for vivax malaria could be used to predict whether a patient would have recurrent malaria.
OUCRU researchers from Indonesia, Nepal, and Vietnam contributed to the newly published WHO research priorities for antimicrobial resistance. These top 40 priorities, developed by the World Health Organization (WHO) with global collaborators, aim to guide research into drug-resistant infections over the next five years, with a special focus on challenges faced by low- and middle-income countries (LMICs).
Researchers at Ludwig Cancer Research have leveraged functional genomics to suppress the function of the mutant histones responsible for driving 80% of incurable childhood brain tumours.
![\"Sarah](\"https://www.ndm.ox.ac.uk/news/professor-sarah-gilbert-appointed-as-deputy-head-of-department/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n